Premium
Clinical diagnostic criteria for IgG4‐related sclerosing cholangitis 2020
Author(s) -
Nakazawa Takahiro,
Kamisawa Terumi,
Okazaki Kazuichi,
Kawa Shigeyuki,
Tazuma Susumu,
Nishino Takayoshi,
Inoue Dai,
Naitoh Itaru,
Watanabe Takayuki,
Notohara Kenji,
Kubota Kensuke,
Ohara Hirotaka,
Tanaka Atsushi,
Takikawa Hajime,
Masamune Atsushi,
Unno Michiaki
Publication year - 2021
Publication title -
journal of hepato‐biliary‐pancreatic sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.63
H-Index - 60
eISSN - 1868-6982
pISSN - 1868-6974
DOI - 10.1002/jhbp.913
Subject(s) - medicine , bile duct , pathological , christian ministry , autoimmune pancreatitis , gastroenterology , biliary tract , primary sclerosing cholangitis , general surgery , pancreatitis , disease , philosophy , theology
Several years have passed since the clinical diagnostic criteria for IgG4‐related sclerosing cholangitis 2012 were published. New findings and knowledge have accumulated since then. The Research Committees for IgG4‐related Diseases and for Intractable Diseases of the Liver and Biliary Tract, in association with the Ministry of Health, Labor, and Welfare of Japan and the Japan Biliary Association, have established a working group consisting of researchers specializing in IgG4‐SC and have drawn up new clinical diagnostic criteria for IgG4‐SC 2020. The diagnosis of IgG4‐SC is based on a combination of the following six criteria: (a) narrowing of the intra‐ or extrahepatic bile duct; (b) thickening of the bile duct wall; (c) serological findings; (d) pathological findings; (e) other organ involvement; and (f) effectiveness of steroid therapy. These new diagnostic criteria for IgG4‐SC are useful in practice for general physicians and other non‐specialists.